Landscapes / Companies
BioCryst Pharmaceuticals not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 7 in all
Trials
3 active
24 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Plasma kallikrein inhibitor |
Approved | Aug 2031Phase 3 trial completes | |||
| Next date | Aug 2031 · Phase 3 trial completes | ||||
| Also tested for | Hereditary Angioedema, HAE and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2026Phase 1 trial completes | |||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Netherton Syndrome | ||||
| Open drug page | |||||
About
- No active trial
- avoralstat, BCX10013, BCX9930, Galidesivir, Peramivir
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021